Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition

EMT and Dissemination Precede Pancreatic Tumor Formation

(2012) Andrew D. Rhim et al.   CELL

Benefits of menopausal hormone therapy—timing is key

(2012) Andrea R. Genazzani et al.   Nature Reviews Endocrinology

EMT: A new vision of hypoxia promoting cancer progression

(2011) Jian Jiang et al.   CANCER BIOLOGY & THERAPY

Characterization of a cell culture model for clinically aggressive hepatocellular carcinoma induced by chronic hypoxia

(2011) Hannah van Malenstein et al.   CANCER LETTERS

Effects of dietary flavonoids, luteolin, and quercetin on the reversal of epithelial-mesenchymal transition in A431 epidermal cancer cells

(2011) Yung-Sheng Lin et al.   CANCER SCIENCE

Biomechanical Remodeling of the Microenvironment by Stromal Caveolin-1 Favors Tumor Invasion and Metastasis

(2011) Jacky G. Goetz et al.   CELL

Contact by melanoma cells causes malignant transformation of human epithelial-like stem cells via alpha V integrin activation of transforming growth factor β1 signaling

(2011) Hongyu Sun et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs

(2011) Xiuwen Tang et al.   FREE RADICAL BIOLOGY AND MEDICINE

E-Cadherin loss associated with EMT promotes radioresistance in human tumor cells

(2011) Jan Theys et al.   RADIOTHERAPY AND ONCOLOGY

Epithelial-Mesenchymal Transition in tumor microenvironment

(2011) Yingying Jing et al.   Cell and Bioscience

Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor

(2011) Benjamin Toh et al.   PLOS BIOLOGY

Melanogenesis inhibitors from the desert plant Anastatica hierochuntica in B16 melanoma cells

(2010) Souichi Nakashima et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Beta-elemene inhibits melanoma growth and metastasis via suppressing vascular endothelial growth factor-mediated angiogenesis

(2010) Wenxing Chen et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Luteolin Inhibits Protein Kinase C  and c-Src Activities and UVB-Induced Skin Cancer

(2010) S. Byun et al.   CANCER RESEARCH

Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion

(2010) Li-juan Zhang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Differential regulation of Snail by hypoxia and hyperglycemia in human proximal tubule cells

(2010) Siska Sumual et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Melanoma and Melanocytic Tumors of Uncertain Malignant Potential in Children, Adolescents and Young Adults-The Stanford Experience 1995-2008

(2010) David R. Berk et al.   PEDIATRIC DERMATOLOGY

Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor

(2009) Lei Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Integrins and Mutant p53 on the Road to Metastasis

(2009) Galina Selivanova et al.   CELL

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility

(2009) Sen-itiroh Hakomori   FEBS LETTERS

Reversibility of Epithelial-Mesenchymal Transition (EMT) Induced in Breast Cancer Cells by Activation of Urokinase Receptor-dependent Cell Signaling

(2009) Minji Jo et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Luteolin inhibits invasion of prostate cancer PC3 cells through E-cadherin

(2009) Q. Zhou et al.   MOLECULAR CANCER THERAPEUTICS

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL

Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy

(2008) Yong Lin et al.   CURRENT CANCER DRUG TARGETS

Biliverdin Reductase Mediates Hypoxia-Induced EMT via PI3-Kinase and Akt

(2008) R. Zeng et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY